Holen Sie sich die Stockscreener-App
74.73
0.82%
0.61
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
BSX Posts Q4 Earnings: Should You Buy, Sell or Hold the Stock? - Finviz
Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference - Finviz
Boston Scientific Corp (NYSE:BSX) Emerges as a Prime GARP Candidate - ChartMill
Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference – Company Announcement - Financial Times
Public Sector Pension Investment Board Purchases 903,448 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Illinois Municipal Retirement Fund - MarketBeat
Will Boston Scientific Corporation stock hit new highs in YEAR2025 Trade Ideas & Long-Term Growth Stock Strategies - mfd.ru
Is Boston Scientific Corporation still a buy after recent gainsOptions Play & Momentum Based Trading Signals - mfd.ru
Boston Sci’s Farapulse better than thermal ablation at 4 years - bioworld.com
The Top 5 Analyst Questions From Boston Scientific's Q4 Earnings Call - Finviz
Impax Asset Management Group plc Boosts Holdings in Boston Scientific Corporation $BSX - MarketBeat
Aug EndMonth: Can Boston Scientific Corporation sustain its profitabilityMarket Trend Summary & Precise Trade Entry Recommendations - baoquankhu1.vn
SEISMIC consortium secures EUR 23.5 million IHI grant to pioneer next-generation minimally invasive brain treatments - GlobeNewswire Inc.
Boston Scientific Board Change Puts Growth And Risk Oversight In Focus - Yahoo Finance
Boston Scientific (BSX) stock price edges up after selloff; Farapulse data and March 28 CHAMPION-AF readout in focus - TechStock²
Boston Scientific (NYSE:BSX) Reaches New 12-Month LowTime to Sell? - MarketBeat
Levi & Korsinsky Investigates Possible Securities Fraud by Boston Scientific Corporation (BSX) - marketscreener.com
Boston Scientific Farapulse PFA outperforms thermal ablation in study - massdevice.com
Boston Scientific (BSX) Analyst Ratings and Price Targets Update - GuruFocus
Boston Scientific stock price slips again: BSX extends slide as heart-rhythm worries linger - TechStock²
Fraud Investigation Opened: Levi & Korsinsky Investigates Boston Scientific Corporation (BSX) on Behalf of Shareholders - marketscreener.com
Truist Cuts Boston Scientific Corporation (BSX) Price Target but Maintains Buy After Earnings Pullback - Finviz
Why Analysts See Boston Scientific (BSX) Differently After Target Cuts And A Fair Value Reset - Yahoo Finance
Boston Scientific (NYSE:BSX) Cut to "Hold" at Wall Street Zen - MarketBeat
Boston Scientific stock price slips again after earnings shock as BSX investors eye heart-rhythm sales - TechStock²
Boston Scientific’s Worst Day in 25 Years Surprised Analysts - Bloomberg.com
Boston Scientific to Report Q4 Earnings with Expected Growth - Intellectia AI
Securities Fraud Investigation Into Boston Scientific Corporation (BSX) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Chartmill
Bernstein SocGen lowers Boston Scientific stock price target on EP miss - Investing.com
RBC Capital lowers Boston Scientific stock price target to $115 on 2026 guidance - Investing.com
Boston Scientific stock holds Outperform rating at Evercore despite EP miss - Investing.com
Boston Scientific price target lowered to $110 from $125 at Stifel - Yahoo Finance
Boston Scientific Corp (NYSE:BSX) Reports Strong Q2 2025 Earnings, Surpassing Revenue and EPS Estimates - Chartmill
Boston Scientific’s (BSX) Earnings Implosion Sparks Bullish Options Trade - TipRanks
Boston Scientific (BSX): Analyst Ratings Update and Target Price Changes | BSX Stock News - GuruFocus
Boston Scientific (BSX): Canaccord Genuity Adjusts Price Target, Maintains Buy Rating | BSX Stock News - GuruFocus
Boston Scientific stock rebounds after earnings shock as analysts cut targets on EP worries - TechStock²
The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition - FinancialContent
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Boston Scientific (BSX) - The Globe and Mail
Boston Scientific Corporation Announces Yoshiaki Fujimori to Not Stand for Re-Election as Director - marketscreener.com
Boston Scientific announces planned board director departure - TipRanks
JPMorgan Chase & Co. Issues Pessimistic Forecast for Boston Scientific (NYSE:BSX) Stock Price - MarketBeat
Boston Scientific Announces Board Member Departure - TradingView
JP Morgan Maintains "Overweight" on Boston Scientific (BSX) but Lowers Price Target | BSX Stock News - GuruFocus
Boston Scientific stock rebounds after brutal selloff — what Wall Street watches next - TechStock²
What Happened To Boston Scientific Stock? - Forbes
Investors in Boston Scientific Corporation (BSX) Warned of Potential Securities FraudContact Levi & Korsinsky Today - marketscreener.com
Wells Fargo & Company Has Lowered Expectations for Boston Scientific (NYSE:BSX) Stock Price - MarketBeat
Deutsche Bank Adjusts Boston Scientific PT to $90 From $129, Maintains Buy Rating - marketscreener.com
Boston Scientific Share Performance Hinges on CHAMPION-AF Clinical Trial Results, RBC Says - marketscreener.com
Is Boston Scientific’s Bull Thesis Still Intact? - Trefis
BSX: Wells Fargo Lowers Price Target for Boston Scientific | BSX Stock News - GuruFocus
Evercore ISI Issues Pessimistic Forecast for Boston Scientific (NYSE:BSX) Stock Price - MarketBeat
Boston Scientific Analyst Slashes Price Target On Disappointing 2026 Outlook - Benzinga
Check Out What Whales Are Doing With BSX - Benzinga
Boston Scientific price target lowered to $95 from $120 at Truist - TipRanks
UBS Adjusts Boston Scientific Price Target to $120 From $140, Maintains Buy Rating - marketscreener.com
Truist Cuts Price Target on Boston Scientific to $95 From $120, Keeps Buy Rating - marketscreener.com
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term - Yahoo Finance
Navigating the MedTech Correction: A Deep-Dive into Boston Scientific (NYSE: BSX) - FinancialContent
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Caribou Biosciences (CRBU) and Boston Scientific (BSX) - The Globe and Mail
Needham Adjusts Price Target on Boston Scientific to $97 From $121, Maintains Buy Rating - marketscreener.com
Citigroup Adjusts Price Target on Boston Scientific to $102 From $130, Maintains Buy Rating - marketscreener.com
Jefferies Adjusts Price Target on Boston Scientific to $120 From $132, Maintains Buy Rating - marketscreener.com
Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results - Yahoo Finance
Boston Scientific stock tries to steady after an 18% earnings drop put EP business on edge - TechStock²
Needham & Company LLC Cuts Boston Scientific (NYSE:BSX) Price Target to $97.00 - MarketBeat
Boston Scientific (NYSE:BSX) Given New $95.00 Price Target at Truist Financial - MarketBeat
Morgan Stanley Has Lowered Expectations for Boston Scientific (NYSE:BSX) Stock Price - MarketBeat
BTIG Adjusts Price Target on Boston Scientific to $110 From $132, Maintains Buy Rating - marketscreener.com
Goldman Sachs Adjusts Price Target on Boston Scientific to $99 From $112, Maintains Buy Rating - marketscreener.com
1.38%
0.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):